Unknown

Dataset Information

0

Pediatric Hodgkin lymphoma: trade-offs between short- and long-term mortality risks.


ABSTRACT: As pediatric Hodgkin lymphoma (HL) survival rates approach > 95%, treatment decisions are increasingly based on minimizing late effects. Using a model-based approach, we explored whether the addition of radiotherapy contributes to improved overall long-term survival. We developed a state-transition model to simulate the lifetime HL clinical course, and we compared 2 treatment strategies: chemotherapy alone (CT) and chemoradiotherapy (CRT). Data on HL relapse, late recurrence, and excess second cancer and cardiac late-effects mortality were estimated from the published literature and databases. Outcomes included conditional life expectancy, cause-specific mortality, and proportion alive at age 50. For a hypothetical cohort of HL patients (diagnosis age 15), conditional life expectancy was 57.2 years with CT compared with 56.4 years with CRT. Estimated lifetime HL mortality risk was 3.6% with CT versus 2.2% with CRT. In contrast, combined risk of excess late-effects mortality was lower for CT (1.8% vs 7.4% with CRT). Among those alive at age 50, only 9.2% of those initially treated with CT were at risk for radiation-related late effects (100% for CRT). Initial treatment with CT may be associated with longer average per-person life expectancy. These results support the need for careful consideration of the risk-benefit profile of radiation as frontline therapy in pediatric patients.

SUBMITTER: Yeh JM 

PROVIDER: S-EPMC3447778 | biostudies-literature | 2012 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pediatric Hodgkin lymphoma: trade-offs between short- and long-term mortality risks.

Yeh Jennifer M JM   Diller Lisa L  

Blood 20120723 11


As pediatric Hodgkin lymphoma (HL) survival rates approach > 95%, treatment decisions are increasingly based on minimizing late effects. Using a model-based approach, we explored whether the addition of radiotherapy contributes to improved overall long-term survival. We developed a state-transition model to simulate the lifetime HL clinical course, and we compared 2 treatment strategies: chemotherapy alone (CT) and chemoradiotherapy (CRT). Data on HL relapse, late recurrence, and excess second c  ...[more]

Similar Datasets

| S-EPMC8168246 | biostudies-literature
| S-EPMC10821973 | biostudies-literature
| S-EPMC10293278 | biostudies-literature
| S-EPMC7260802 | biostudies-literature
| S-EPMC7888633 | biostudies-literature
| S-EPMC3056636 | biostudies-literature
| S-EPMC9201768 | biostudies-literature
| S-EPMC7691110 | biostudies-literature
| S-EPMC9239945 | biostudies-literature
| S-EPMC10711168 | biostudies-literature